Abstract
Background Individuals with chronic pain (CP) not only endure the direct burden of the pain but also experience various symptoms, including sleep disturbances and fatigue, which deteriorate their quality of life. Notably, these symptoms closely resemble those observed in ‘long COVID’, a prolonged health complication that can arise after coronavirus disease 2019 (COVID-19) infection. However, the similarities between them have not yet been explored. Therefore, this study aimed to investigate the relationship between CP and long COVID using Japanese epidemiological data.
Methods Utilizing the Japan COVID-19 and Society Internet Survey in 2022, an Internet-based survey involving 32,000 participants, we analysed data on the presence of CP, history of COVID-19 infection, and presence of 17 long COVID-like symptoms, including gastrointestinal upset, back pain, limb/joint pain, headache, chest pain, shortness of breath, dizziness, sleep disorder, hearing disorder, taste disorder, smell disorder, memory impairment, poor concentration, hair loss, decreased libido, fatigue, and cough.
Results Individuals with history of COVID-19 experienced a significantly greater number of long COVID-like symptoms (median: 5) compared to those with neither COVID-19 nor CP (median: 4, p < 0.001). However, individuals with CP alone and those with both COVID-19 and CP exhibited an even greater number of symptoms (median: 8 and 9, respectively). Additionally, individuals with CP exhibited greater prevalence odds for 15 of the 17 symptoms than those without CP or COVID-19 (p < 0.001).
Conclusions Altogether, our study suggests that the long COVID-like symptoms are not specifically related to COVID-19, but CP is an independent risk factor for these symptoms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grants [grant numbers 21H04856, 20K10467, 20K19633, 20K1372, 24K00498, and 24K02541], the JST Grant [grant number: JPMJPF2017], the Health Labor Sciences Research Grant [grant number: 21HA2016], the grant for 2021–2022 Strategic Research Promotion [grant number: SK202116] of Yokohama City University, and the research program on Using Health Metrics to Monitor and Evaluate the Impact of Health Policies, conducted at the Tokyo Foundation for Policy Research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the Keio University School of Medicine and ethics committee of the Osaka International Cancer Centre, Osaka Prefectural Hospital Organization gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Sharing Statement
The Japan COVID-19 and Society Internet Survey (JACSIS) study dataset is available upon reasonable request to the corresponding author.
